Pulmonx to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Pulmonx (Nasdaq: LUNG) announced that its management team will participate in two upcoming investor events. The company will attend the Wells Fargo Healthcare Conference for 1x1 meetings on Wednesday, September 9 in Boston, MA, and the Lake Street Best Ideas Growth (BIG10) Conference for 1x1 meetings on Thursday, September 10 in New York, NY.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

REDWOOD CITY, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”) a global leader in minimally invasive treatments for severe lung disease, today announced that management will participate in the following upcoming investor conferences:

Wells Fargo Healthcare Conference
Format: 1x1 meetings
Date: Wednesday, September 9
Location: Boston, MA

Lake Street Best Ideas Growth (BIG10) Conference
Format: 1x1 meetings
Date: Thursday, September 10
Location: New York, NY

About Pulmonx Corporation
Pulmonx Corporation (Nasdaq: LUNG) is a global leader in minimally invasive treatments for chronic obstructive pulmonary disease (COPD). Pulmonx’s Zephyr^® Endobronchial Valve, Chartis^® Pulmonary Assessment System, LungTraX^® Platform, and StratX^® Lung Analysis Reports are designed to assess and treat patients with severe emphysema/COPD who despite medical management are still profoundly symptomatic. Pulmonx received U.S. Food and Drug Administration (FDA) Premarket Approval (PMA) to commercialize the Zephyr^® Endobronchial Valve following its designation as a “breakthrough device.” The Zephyr Valve is commercially available in more than 25 countries, is included in global treatment guidelines and is widely considered a standard of care treatment option for improving breathing, activity and quality of life in patients with severe emphysema. For more information on the Zephyr Valves and the company, please visit www.Pulmonx.com.

Pulmonx^®, AeriSeal^®, Chartis^®, LungTraX^®, StratX^®, and Zephyr^® are registered trademarks of Pulmonx Corporation.  

Contact
Brian Johnston or Webb Campbell
Gilmartin Group
investors@pulmonx.com

FAQ

When will Pulmonx (Nasdaq: LUNG) attend the Wells Fargo Healthcare Conference?

Pulmonx management plans to attend the Wells Fargo Healthcare Conference on Wednesday, September 9. According to Pulmonx, the company will participate in 1x1 investor meetings during the event in Boston, Massachusetts.

What is the format of Pulmonx’s participation at the Wells Fargo Healthcare Conference?

Pulmonx plans to participate in a 1x1 meetings format at the Wells Fargo Healthcare Conference. According to Pulmonx, these meetings will be held with investors on September 9 in Boston, MA.

When is Pulmonx (LUNG) presenting at the Lake Street Best Ideas Growth (BIG10) Conference?

Pulmonx management expects to take part in the Lake Street Best Ideas Growth (BIG10) Conference on Thursday, September 10. According to Pulmonx, participation will be via 1x1 investor meetings in New York, New York.

What is the meeting format for Pulmonx at the Lake Street BIG10 Conference?

Pulmonx plans to hold 1x1 meetings with investors at the Lake Street Best Ideas Growth (BIG10) Conference. According to Pulmonx, these meetings are scheduled for Thursday, September 10 in New York, NY.

Where are Pulmonx’s upcoming investor conferences in September being held?

Pulmonx’s September investor events are scheduled in Boston, MA and New York, NY. According to Pulmonx, Boston hosts the Wells Fargo Healthcare Conference and New York hosts the Lake Street BIG10 Conference.